GGrantIndex
Sort

53,477 grants matching addiction

16/24 Healthy Brain and Child Development National Consortium

$2,078,944
Nathan A Fox · Univ Of Maryland, College Park · U01 · FY2024 · DA

Neurocomputational mechanisms of learning and decision-making and their disruption in addiction

$2,077,777
Thorsten Kahnt · National Institute On Drug Abuse · ZIA · FY2023 · DA

Neuroscience, Immunology, Social Adversity and the Roots of Addictive Behaviors: Toward a New Framework for Drug Use Etiology and Prevention

$2,077,136
Steven R Beach · University Of Georgia · P50 · FY2022 · DA

Illuminating neural coding mechanisms using in vivo calcium imaging in freely behaving rodents

$2,076,909
Da-Ting Lin · National Institute On Drug Abuse · ZIA · FY2021 · DA

Mouse models of stress disorders and addiction

$2,075,723
Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA

2/24 Healthy Brain and Child Development National Consortium

$2,074,969
Pat R Levitt · Children'S Hospital Of Los Angeles · U01 · FY2024 · DA

Psychotherapy Development Research Center

$2,074,078
Bruce James Rounsaville · Yale University · P50 · FY2009 · DA

Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center

$2,073,692
Peter D. Friedmann · Baystate Medical Center, Inc. · UG1 · FY2022 · DA

Assessment,Treatment, and Pharmacological Interventions in Alcoholic Patients

$2,072,970
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA

Biology of Neuroendocrine Peptides

$2,070,647
Marc R Montminy · Salk Institute For Biological Studies · P01 · FY2013 · DK

Neurocircuitry Underlying DBS Effects in OCD: A Window Into Mechanisms of Action

$2,070,224
Suzanne N Haber · University Of Rochester · P50 · FY2011 · MH

Dissecting the role of mPFC dynorphin circuits in the modulation of different pain states

$2,068,842
Patrick L Sheets · Indiana University Indianapolis · RF1 · FY2024 · NS

NIDA Clinical Trials Network: New York Node

$2,068,510
John P Rotrosen · New York University School Of Medicine · UG1 · FY2022 · DA

GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION

$2,066,353
University Of Utah · P01 · FY2003 · HL

Functional and Pharmacological Significance of Receptor Heteromers in the CNS

$2,065,937
Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2015 · DA

Center for Biomedical Research Excellence, Epigenomics of Development and Disease

$2,065,893
Roxanne A Vaughan · University Of North Dakota · P20 · FY2014 · GM

Phase III Study of a Nicotine Vaccine for Smoking Cessation

$2,065,470
Paul D Kessler · Nabi Biopharmaceuticals · RC2 · FY2010 · DA

Centers for Cancer Systems Therapeutics (CaST)

$2,065,461
Andrea Califano · Columbia University Health Sciences · U54 · FY2019 · CA

Advancing the Development of a Humanized Anti-cocaine Monoclonal Antibody

$2,065,159
Andrew B Norman · University Of Cincinnati · U01 · FY2016 · DA

Effects of Public Information in Cancer (EPIC Center)

$2,064,973
Robert C. Hornik · University Of Pennsylvania · P50 · FY2006 · CA

Neuroscience, Immunology, Social Adversity and the Roots of Addictive Behaviors: Toward a New Framework for Drug Use Etiology and Prevention

$2,064,702
Gene H Brody · University Of Georgia · P50 · FY2021 · DA

Center for Biomedical Research Excellence, Epigenomics of Development and Disease

$2,063,368
Roxanne A Vaughan · University Of North Dakota · P20 · FY2015 · GM

Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration

$2,062,691
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2023 · DA

Center for Research Improving Treatment of Drug Abuse

$2,062,186
University Of Pennsylvania · P60 · FY2002 · DA

Effects of Public Information in Cancer (EPIC Center)

$2,061,995
University Of Pennsylvania · P50 · FY2004 · CA